A detailed history of Advisor Partners LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Advisor Partners LLC holds 6,569 shares of MRNA stock, worth $431,911. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,569
Previous 4,329 51.74%
Holding current value
$431,911
Previous $746,000 25.74%
% of portfolio
0.07%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$117.13 - $176.59 $262,371 - $395,561
2,240 Added 51.74%
6,569 $938,000
Q1 2022

Apr 27, 2022

SELL
$126.46 - $235.05 $82,325 - $153,017
-651 Reduced 13.07%
4,329 $746,000
Q4 2021

Feb 04, 2022

BUY
$225.82 - $368.51 $16,484 - $26,901
73 Added 1.49%
4,980 $1.27 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $1.09 Million - $2.38 Million
4,907 New
4,907 $1.89 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Advisor Partners LLC Portfolio

Follow Advisor Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.